<article article-type="case-study" dtd-version="1.4" id="jpr370100" xml:lang="en"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JPGN Rep</journal-id><journal-id journal-id-type="iso-abbrev">JPGN Rep</journal-id><journal-id journal-id-type="pmc-domain-id">4376</journal-id><journal-id journal-id-type="pmc-domain">jpgnreps</journal-id><journal-id journal-id-type="publisher-id">JPR3</journal-id><journal-title-group><journal-title>JPGN Reports</journal-title></journal-title-group><issn pub-type="epub">2691-171X</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12894056</article-id><article-id pub-id-type="pmcid-ver">PMC12894056.1</article-id><article-id pub-id-type="pmcaid">12894056</article-id><article-id pub-id-type="pmcaiid">12894056</article-id><article-id pub-id-type="pmid">41695058</article-id><article-id pub-id-type="doi">10.1002/jpr3.70100</article-id><article-id pub-id-type="publisher-id">JPR370100</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Case Report</subject><subj-group subj-group-type="heading"><subject>Pancreatology</subject></subj-group></subj-group></article-categories><title-group><article-title>A rare case of pediatric autoimmune pancreatitis and autoimmune hepatitis in a patient with sickle cell disease</article-title><alt-title alt-title-type="left-running-head">ABI‐AAD <sc>et al.</sc>
</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="jpr370100-cr-0001"><name name-style="western"><surname>Abi‐Aad</surname><given-names initials="SJ">Sasha‐Jane</given-names></name><contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0009-0005-5990-9424</contrib-id><xref ref-type="aff" rid="jpr370100-aff-0001">
<sup>1</sup>
</xref><address><email>sashajane@usf.edu</email></address></contrib><contrib contrib-type="author" id="jpr370100-cr-0002"><name name-style="western"><surname>Edward</surname><given-names initials="M">Michelle</given-names></name><xref ref-type="aff" rid="jpr370100-aff-0002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" id="jpr370100-cr-0003"><name name-style="western"><surname>Germain</surname><given-names initials="D">David</given-names></name><xref ref-type="aff" rid="jpr370100-aff-0003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" id="jpr370100-cr-0004"><name name-style="western"><surname>Gomez‐Esquivel</surname><given-names initials="R">Rene</given-names></name><contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-4666-1544</contrib-id><xref ref-type="aff" rid="jpr370100-aff-0001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" id="jpr370100-cr-0005"><name name-style="western"><surname>Khalaf</surname><given-names initials="R">Racha</given-names></name><contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-5010-8149</contrib-id><xref ref-type="aff" rid="jpr370100-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="jpr370100-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition</named-content>
<institution>University of South Florida Morsani College of Medicine</institution>
<city>Tampa</city>
<named-content content-type="country-part">Florida</named-content>
<country country="US">USA</country>
</aff><aff id="jpr370100-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine/Pediatrics</named-content>
<institution>University of South Florida Morsani College of Medicine</institution>
<city>Tampa</city>
<named-content content-type="country-part">Florida</named-content>
<country country="US">USA</country>
</aff><aff id="jpr370100-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>University of South Florida Morsani College of Medicine</institution>
<city>Tampa</city>
<named-content content-type="country-part">Florida</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold> Sasha‐Jane Abi‐Aad, 13101 Bruce B. Down's Blvd. Tampa, FL 33612, USA.<break/>
Email: <email>sashajane@usf.edu</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>10</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2026</year></pub-date><volume>7</volume><issue seq="270">1</issue><issue-id pub-id-type="pmc-issue-id">507520</issue-id><issue-id pub-id-type="doi">10.1002/jpr3.v7.1</issue-id><fpage>142</fpage><lpage>146</lpage><history><date date-type="rev-recd"><day>14</day><month>8</month><year>2025</year></date><date date-type="received"><day>15</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>01</day><month>10</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>21</day><month>10</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>02</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2026-02-16 15:25:13.347"><day>16</day><month>02</month><year>2026</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">© 2025 The Author(s). <italic toggle="yes">JPGN Reports</italic> published by Wiley Periodicals LLC on behalf of The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.</copyright-statement><license><ali:license_ref content-type="ccbylicense" specific-use="textmining" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/" xmlns:xlink="http://www.w3.org/1999/xlink">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="JPR3-7-142.pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/><self-uri content-type="pdf" xlink:href="file:JPR3-7-142.pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/><abstract><title>Abstract</title><p>Concurrent pediatric autoimmune pancreatitis (AIP) and autoimmune hepatitis (AIH) are rarely reported, and no established pediatric‐specific guidelines are available to guide the diagnosis and management of these conditions in children. While AIP and AIH share an underlying autoimmune mechanism of injury, marked by chronic inflammatory changes such as fibrosis, sclerosis, and infiltration of mononuclear cells like plasma cells and lymphocytes, their concurrent occurrence is infrequent, as they remain distinct clinical entities. In this case report, we present a case of concurrent AIH and AIP with treatment challenges secondary to underlying sickle cell disease (SCD) in an 11‐year‐old female. Herein, we discuss not only the diagnostic challenges faced when determining the cause of cholestasis in a patient with SCD but also the therapeutic strategies adopted throughout the care of this patient.</p></abstract><kwd-group><kwd id="jpr370100-kwd-0001">hepatopancreatitis</kwd><kwd id="jpr370100-kwd-0002">IgG4‐related disease</kwd><kwd id="jpr370100-kwd-0003">pediatric autoimmune disease</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>
<institution-wrap><institution>Cystic Fibrosis Foundation</institution></institution-wrap>
</funding-source><award-id>005206Q123</award-id><award-id>005583Q123</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="1"/><page-count count="5"/><word-count count="2355"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2026</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.8 mode:remove_FC converted:11.02.2026</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation id="jpr370100-cit-0011" publication-type="journal">
<string-name name-style="western">
<surname>Abi‐Aad</surname>
<given-names>S‐J</given-names>
</string-name>, <string-name name-style="western">
<surname>Edward</surname>
<given-names>M</given-names>
</string-name>, <string-name name-style="western">
<surname>Germain</surname>
<given-names>D</given-names>
</string-name>, <string-name name-style="western">
<surname>Gomez‐Esquivel</surname>
<given-names>R</given-names>
</string-name>, <string-name name-style="western">
<surname>Khalaf</surname>
<given-names>R</given-names>
</string-name>. <article-title>A rare case of pediatric autoimmune pancreatitis and autoimmune hepatitis in a patient with sickle cell disease</article-title>. <source>JPGN Rep</source>. <year>2026</year>;<volume>7</volume>:<fpage>142</fpage>‐<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1002/jpr3.70100</pub-id>
</mixed-citation>
</p><fn-group><fn id="jpr370100-note-0001"><p>Sasha‐Jane Abi‐Aad and Michelle Edward contributed equally to this study.</p></fn></fn-group></notes></front><body><sec id="jpr370100-sec-0010"><label>1</label><title>INTRODUCTION</title><p>Pediatric autoimmune pancreatitis (P‐AIP) is rare, with a prevalence of 3.9% in the INSPPIRE cohort.<xref ref-type="bibr" rid="jpr370100-bib-0001">
<sup>1</sup>
</xref> There are two distinct subtypes. Type 1 is an immunoglobulin (Ig) G4 related disease (IgG4‐RD), a systemic disease typically seen in older individuals and characterized by elevated serum IgG4, periductal lymphocytes infiltration, and abundant IgG4 plasma cells, and type 2 is more common in younger patients and marked by ductal lymphocytic infiltration and fibrosis with minimal IgG4 plasma cells.<xref ref-type="bibr" rid="jpr370100-bib-0002">
<sup>2</sup>
</xref> While adult‐AIP and IgG4‐RD require a combination of radiological, laboratory, and histopathological criteria, diagnosing P‐AIP is more challenging as manifestations may differ and subtypes can overlap.<xref ref-type="bibr" rid="jpr370100-bib-0003">
<sup>3</sup>
</xref> Pediatric autoimmune hepatitis (AIH) is also a rare disease with a prevalence of 2.4–9.9 per 100,000.<xref ref-type="bibr" rid="jpr370100-bib-0004">
<sup>4</sup>
</xref> We report an uncommon case of concurrent pediatric AIP and AIH with elevated serum IgG4 but negative tissue immunostaining, in an 11‐year‐old female with sickle cell disease (SCD).</p></sec><sec id="jpr370100-sec-0020"><label>2</label><title>CASE REPORT</title><p>An 11‐year‐old female with SCD (HbSS) and recurrent acute pain crises was seen in the emergency department (ED)for jaundice, epigastric, and chest pain. Five days earlier, during a routine follow‐up, she had abnormal liver enzymes, hyperbilirubinemia, and mild scleral icterus despite a normal review of systems and was advised to hold hydroxyurea for 2 weeks. She returned with severe abdominal pain. On examination, she was tachycardic with scleral icterus and right upper quadrant tenderness; the remainder of the physical exam was unremarkable. Labs showed normocytic normochromic anemia, worsened transaminitis, and conjugated hyperbilirubinemia. Lipase was normal (Table <xref ref-type="table" rid="jpr370100-tbl-0001">1</xref>).</p><table-wrap content-type="Table" id="jpr370100-tbl-0001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Laboratory results from preadmission to postdischarge in an 11‐year‐old girl with SCD presenting to the ED with abdominal pain and jaundice.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000"/><col align="left" span="1" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000"/><col align="left" span="1" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000"/><col align="left" span="1" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000"/><col align="left" span="1" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000"/><col align="left" span="1" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" colspan="1" rowspan="1" valign="bottom"/><th align="left" colspan="1" rowspan="1" valign="bottom">Scheduled follow‐up visit</th><th align="left" colspan="1" rowspan="1" valign="bottom">At admission (ED)</th><th align="left" colspan="1" rowspan="1" valign="bottom">First visit after discharge (1 month later)</th><th align="left" colspan="1" rowspan="1" valign="bottom">50 days after discharge</th><th align="left" colspan="1" rowspan="1" valign="bottom">Reference values</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1" valign="top">Days from first visit</td><td align="left" colspan="1" rowspan="1" valign="top">Day 0</td><td align="left" colspan="1" rowspan="1" valign="top">Day 5</td><td align="left" colspan="1" rowspan="1" valign="top">Day 31</td><td align="left" colspan="1" rowspan="1" valign="top">Day 68</td><td align="left" colspan="1" rowspan="1" valign="top"/></tr><tr><td align="left" colspan="6" rowspan="1" style="background-color:#E7E6E6" valign="top">Laboratory tests</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Hemoglobin</td><td align="left" colspan="1" rowspan="1" valign="top">7.6</td><td align="left" colspan="1" rowspan="1" valign="top">7.9</td><td align="left" colspan="1" rowspan="1" valign="top">8.4</td><td align="left" colspan="1" rowspan="1" valign="top">8.4</td><td align="left" colspan="1" rowspan="1" valign="top">11.5–15.5 g/dL</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">MCV</td><td align="left" colspan="1" rowspan="1" valign="top">87.4</td><td align="left" colspan="1" rowspan="1" valign="top">80.5</td><td align="left" colspan="1" rowspan="1" valign="top">88.6</td><td align="left" colspan="1" rowspan="1" valign="top">85.9</td><td align="left" colspan="1" rowspan="1" valign="top">77.0–95.0 fL</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">MCH</td><td align="left" colspan="1" rowspan="1" valign="top">29.1</td><td align="left" colspan="1" rowspan="1" valign="top">29.6</td><td align="left" colspan="1" rowspan="1" valign="top">30.0</td><td align="left" colspan="1" rowspan="1" valign="top">30.4</td><td align="left" colspan="1" rowspan="1" valign="top">27.0–31.2 pg</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">White blood cells</td><td align="left" colspan="1" rowspan="1" valign="top">14</td><td align="left" colspan="1" rowspan="1" valign="top">14.2</td><td align="left" colspan="1" rowspan="1" valign="top">14.2</td><td align="left" colspan="1" rowspan="1" valign="top">14.2</td><td align="left" colspan="1" rowspan="1" valign="top">6.0–17.5 <mml:math display="inline" id="jats-math-1" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mrow><mml:mrow><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:mrow></mml:math>/<mml:math display="inline" id="jats-math-2" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mrow><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:math> L</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">ESR</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">67</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">0–20 mm/h</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">CRP</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">6.3</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">&lt;8.0 mg/L</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">High sensitivity CRP</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">7.4</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">0.01–0.5 mg/dL</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Platelets</td><td align="left" colspan="1" rowspan="1" valign="top">590</td><td align="left" colspan="1" rowspan="1" valign="top">545</td><td align="left" colspan="1" rowspan="1" valign="top">510</td><td align="left" colspan="1" rowspan="1" valign="top">323</td><td align="left" colspan="1" rowspan="1" valign="top">142.0–424.0 <mml:math display="inline" id="jats-math-3" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mrow><mml:mrow><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:mrow></mml:math>/<mml:math display="inline" id="jats-math-4" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mrow><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:math> L</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">AST</td><td align="left" colspan="1" rowspan="1" valign="top">294</td><td align="left" colspan="1" rowspan="1" valign="top">631</td><td align="left" colspan="1" rowspan="1" valign="top">63</td><td align="left" colspan="1" rowspan="1" valign="top">192</td><td align="left" colspan="1" rowspan="1" valign="top">5–34 U/L</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">ALT</td><td align="left" colspan="1" rowspan="1" valign="top">131</td><td align="left" colspan="1" rowspan="1" valign="top">239</td><td align="left" colspan="1" rowspan="1" valign="top">37</td><td align="left" colspan="1" rowspan="1" valign="top">141</td><td align="left" colspan="1" rowspan="1" valign="top">5–55 U/L</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">GGT</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">22</td><td align="left" colspan="1" rowspan="1" valign="top">39</td><td align="left" colspan="1" rowspan="1" valign="top">51</td><td align="left" colspan="1" rowspan="1" valign="top">9–36 U/L</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Total bilirubin</td><td align="left" colspan="1" rowspan="1" valign="top">8.2</td><td align="left" colspan="1" rowspan="1" valign="top">16.1</td><td align="left" colspan="1" rowspan="1" valign="top">5.3</td><td align="left" colspan="1" rowspan="1" valign="top">6.5</td><td align="left" colspan="1" rowspan="1" valign="top">0.1–1.2 mg/dL</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Direct bilirubin</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">10.3</td><td align="left" colspan="1" rowspan="1" valign="top">1.9</td><td align="left" colspan="1" rowspan="1" valign="top">2.7</td><td align="left" colspan="1" rowspan="1" valign="top">0.1–0.5 mg/dL</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">ALP</td><td align="left" colspan="1" rowspan="1" valign="top">247</td><td align="left" colspan="1" rowspan="1" valign="top">351</td><td align="left" colspan="1" rowspan="1" valign="top">248</td><td align="left" colspan="1" rowspan="1" valign="top">371</td><td align="left" colspan="1" rowspan="1" valign="top">141–460 U/L</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Albumin</td><td align="left" colspan="1" rowspan="1" valign="top">3.5</td><td align="left" colspan="1" rowspan="1" valign="top">2.8</td><td align="left" colspan="1" rowspan="1" valign="top">3.7</td><td align="left" colspan="1" rowspan="1" valign="top">3.5</td><td align="left" colspan="1" rowspan="1" valign="top">3.5–5.0 g/dL</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Total protein</td><td align="left" colspan="1" rowspan="1" valign="top">9.2</td><td align="left" colspan="1" rowspan="1" valign="top">9.4</td><td align="left" colspan="1" rowspan="1" valign="top">8.2</td><td align="left" colspan="1" rowspan="1" valign="top">9.2</td><td align="left" colspan="1" rowspan="1" valign="top">6–8 g/dL</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Prothrombin time</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">17.7</td><td align="left" colspan="1" rowspan="1" valign="top">11.0</td><td align="left" colspan="1" rowspan="1" valign="top">14.3</td><td align="left" colspan="1" rowspan="1" valign="top">10.0–14.4 s</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">INR</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">1.4</td><td align="left" colspan="1" rowspan="1" valign="top">1.1</td><td align="left" colspan="1" rowspan="1" valign="top">1.2</td><td align="left" colspan="1" rowspan="1" valign="top"/></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Lipase</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">21</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">‐</td><td align="left" colspan="1" rowspan="1" valign="top">4–78 U/L</td></tr><tr><td align="left" colspan="6" rowspan="1" style="background-color:#E7E6E6" valign="top">
<bold>Anthropometrics</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Weight (kg)</td><td align="left" colspan="1" rowspan="1" valign="top">38.6</td><td align="left" colspan="1" rowspan="1" valign="top">38.6</td><td align="left" colspan="1" rowspan="1" valign="top">39.4</td><td align="left" colspan="1" rowspan="1" valign="top">43.1</td><td align="left" colspan="1" rowspan="1" valign="top"/></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Height (cm)</td><td align="left" colspan="1" rowspan="1" valign="top">152.3</td><td align="left" colspan="1" rowspan="1" valign="top">152.3</td><td align="left" colspan="1" rowspan="1" valign="top">153.6</td><td align="left" colspan="1" rowspan="1" valign="top">154.5</td><td align="left" colspan="1" rowspan="1" valign="top"/></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">BMI <mml:math display="inline" id="jats-math-5" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi>kg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:mrow></mml:math>)</td><td align="left" colspan="1" rowspan="1" valign="top">16.6</td><td align="left" colspan="1" rowspan="1" valign="top">16.6</td><td align="left" colspan="1" rowspan="1" valign="top">16.7</td><td align="left" colspan="1" rowspan="1" valign="top">18.1</td><td align="left" colspan="1" rowspan="1" valign="top"/></tr></tbody></table><table-wrap-foot><fn id="jpr370100-tbl1-note-0001"><p>Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CRP, C‐reactive protein; ED, emergency department; ESR, erythrocyte sedimentation rate; GGT, gamma‐glutamyl transferase; INR, international normalized ratio; MCH, mean corpuscular haemoglobin; MCV, mean corpuscular concentration; SCD, sickle cell disease.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Workup was ordered (Supporting Information <xref ref-type="supplementary-material" rid="jpr370100-suppl-0001">S1</xref>). Magnetic resonance cholangiopancreatography (MRCP) revealed a 2.3 cm mass at the uncinate process with extensive abnormal pancreatic signal (Figure <xref ref-type="fig" rid="jpr370100-fig-0001">1A–C</xref>), and mild heterogenous liver enhancement. Endoscopic ultrasound (EUS) revealed an isoechoic, homogenous mass with diffuse echogenicity and hyperechoic strands in the body and tail (Figure <xref ref-type="fig" rid="jpr370100-fig-0001">1D–G</xref>). Fine needle aspiration of the mass revealed chronic inflammation (Figure <xref ref-type="fig" rid="jpr370100-fig-0002">2A</xref>). Liver biopsy showed cholestatic hepatitis with mild interface hepatitis, and increased plasma cells (Figure <xref ref-type="fig" rid="jpr370100-fig-0002">2B,C</xref>). Immunostaining was negative for IgG4+ plasma cells in both tissues; however, antismooth muscle antibody (SMA) was 75 (reference &lt;20 U), total serum IgG 3514 (reference 480–1530 mg/dL) and serum IgG4 of 282.4 (reference 2.0–115.0 mg/dL) (Supporting Information <xref ref-type="supplementary-material" rid="jpr370100-suppl-0001">S1</xref>). She was diagnosed with both AIP and AIH and discharged on prednisone 40 mg following a 14‐day admission.</p><fig fig-type="Figure" id="jpr370100-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>(A) T2 axial MRI section, demonstrating focal mass‐like area (yellow arrow) of high T2 signal in pancreatic head and uncinate process measuring 2.1 ×1.8 cm with no significant associated bile duct or pancreatic ductal distention. There is a thin peripheral hypointense capsule‐like rim on T2 imaging. (B) T1 axial MRI section with gadolinium contrast demonstrating homogenous enhancement similar to normal pancreas throughout the mass like area (yellow arrow). (C) T2 axial MRI section, showing downstream edema throughout the body and tail (white arrow) of the pancreas. (D) EUS image showing an oval, isoechoic and homogenous mass (yellow arrow) at the uncinate of the pancreas, measuring 19 mm in maximal cross‐sectional diameter. (E) EUS image showing the tail (Top‐ white arrow) of the pancreas with normal caliber pancreatic duct (red arrow). The echogenicity is slighly heterogenous described as “salt pepper” with some hyperechoigenic strands which the apperance is considered normal for the patient's age. (F) EUS image showing homogenous parenchyma, with no sign of significant endosonographic abnormality in the left or right lobes of the liver. No focal pathology or masses were identified. This image only shows the left lobe of the liver. There was no sign of significant endosonographic abnormality in the common bile duct. The maximum diameter of the duct was 3 mm. Ducts of normal caliber and with regular contour were identified. No masses were seen. EUS, endoscopic ultrasound; MRI, magnetic resonance imaging.</p></caption><graphic id="jats-graphic-1" orientation="portrait" position="anchor" xlink:href="JPR3-7-142-g001.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><fig fig-type="Figure" id="jpr370100-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Histopathology photomicrograph stained of an 11‐year‐old girl with sickle cell disease, jaundice and a pancreatic mass. (A) H&amp;E section of the pancreatic mass showing residual pancreatic tissue with fibrosis and chronic inflammation (magnified ×100). (B) H&amp;E section from the liver showing cholestatic hepatitis with extensive feathery degeneration (magnified ×200). (C) Section from the portal tract showing lymphoplasmacytic infiltration with increased plasma cells and bile ductular proliferation (magnified ×200). H&amp;E, hematoxylin and eosin.</p></caption><graphic id="jats-graphic-3" orientation="portrait" position="anchor" xlink:href="JPR3-7-142-g002.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><p>Two days after discharge, she experienced an acute pain crisis attributed to prednisone and was switched to 9 mg of budesonide. At follow‐up, liver enzymes improved, pancreatic function normalized (elastase 469 mcg/g), and azathioprine 150 mg was initiated alongside budesonide. Fifty days later, aspartate aminotransferase and alanine aminotransferase worsened due to poor compliance, reflected by diminished 6‐thioguanine levels (Table <xref ref-type="table" rid="jpr370100-tbl-0001">1</xref>); however, MRCP revealed a stable pancreatic mass with reduced signals. Following motivational interviewing, liver enzymes and hepatic synthetic function improved, and budesonide tapering began after 5 months. By 9 months, she was completely off budesonide, and MRCP demonstrated resolution of the mass. She remains on azathioprine and has been in remission for &gt;20 months.</p></sec><sec id="jpr370100-sec-0030" sec-type="discussion"><label>3</label><title>DISCUSSION</title><p>This is a rare case of concurrent AIH and AIP in a pediatric patient with SCD. The patient met INSPPIRE diagnostic criteria for P‐AIP, presenting with abdominal pain, a pancreatic mass, focal enlargement with hypointense capsule‐like rim on T2 imaging, dense lymphocytic infiltrates, and serum IgG4 &gt; 2x the upper limit normal (ULN), despite normal lipase and absent IgG4 immunostaining. According to INSPPIRE, P‐AIP diagnosis can be based solely on clinical and imaging findings. Pancreatic enzymes may be normal in up to 57% of cases, and EUS‐biopsy is often not feasible in children. Additionally, P‐AIP may have overlapping features of both subtypes, and subtype differentiation is more challenging in pediatric patients, with elevated serum IgG4 reported in only 22% of cases.<xref ref-type="bibr" rid="jpr370100-bib-0003">
<sup>3</sup>
</xref> She had elevated serum IgG4 consistent with type 1 AIP, but lacked IgG4 plasma cells on immunostaining, more characteristic of type 2. Possible explanations are inadequate tissue sampling, early disease, or overlapping features, previously reported in pediatric cases. Concurrent AIH was diagnosed using simplified International Autoimmune Hepatitis Group (IAIHG) criteria: elevated total serum IgG (&gt;1.10 x ULN), positive anti‐SMA, histological evidence of active hepatitis, and exclusion of other causes.<xref ref-type="bibr" rid="jpr370100-bib-0005">
<sup>5</sup>
</xref>
</p><p>It is unclear whether AIP or AIH developed first; however, their concurrent presentation with elevated serum IgG4 raises the possibility of IgG4‐RD involving both the pancreas and liver. According to the 2020 revised IgG4‐RD criteria, a diagnosis is possible when clinical or radiologic features show a mass, or diffuse or localized swelling, with serum IgG4 &gt; 135 mg/dL. However, a definite diagnosis requires characteristic histopathology.<xref ref-type="bibr" rid="jpr370100-bib-0006">
<sup>6</sup>
</xref> The patient had a pancreatic mass with serum IgG4 of 282.4 mg/dL, making IgG4‐RD a possible differential. In addition, hepatic involvement may be categorized as either IgG4‐related AIH or IgG4‐related hepatopathy. While there's no single definition for IgG4 AIH, most agree that it requires meeting the established criteria for classical AIH, with IgG4 plasma cell infiltration. In contrast, IgG4‐related hepatopathy refers to liver and bile duct injury in the context of IgG4‐RD, without meeting AIH criteria.<xref ref-type="bibr" rid="jpr370100-bib-0007">
<sup>7</sup>
</xref> The patient met AIH criteria and had high serum IgG4 but lacked IgG4 immunostaining in the liver.</p><p>The simultaneous occurrence of AIP and AIH in the absence of prior autoimmune disease, along with high serum IgG4, suggests a possible uncharacterized variant of IgG4‐AIP and AIH. Most IgG4‐RD occur in adults, with few pediatric reports, which limit our understanding of how it manifests in children.</p><p>The presence of SCD introduced additional diagnostic and management challenges. Liver injury is not uncommon in SCD, and SCD hepatopathy includes acute and chronic manifestations, such as acute sickle cell hepatic crisis, intrahepatic cholestasis, cholelithiasis, iron overload, or drug‐induced liver injury.<xref ref-type="bibr" rid="jpr370100-bib-0008">
<sup>8</sup>
</xref> She had stable normocytic anemia, indicating no acute sickle cell crisis. The absence of sickling or iron deposition on histology, but the presence of lymphocytic infiltration, makes SCD hepatopathy unlikely and supports the diagnosis of autoimmune disease. The patient did not tolerate prednisone due to worsened pain crises and was transitioned to budesonide, a second‐line therapy for AIP and AIH. A meta‐analysis reported that systemic corticosteroids increase hospital readmission risk due to pain crises in SCD<xref ref-type="bibr" rid="jpr370100-bib-0009">
<sup>9</sup>
</xref>; however, another study found no such risk with inhaled corticosteroids,<xref ref-type="bibr" rid="jpr370100-bib-0010">
<sup>10</sup>
</xref> indicating potential safe use of budesonide in this population.</p><p>This case highlights the efficacy of other steroids like budesonide in managing autoimmune disorders in pediatric patients intolerant to prednisone. Future research should investigate the role of SCD in early‐onset autoimmune disorders and establish management guidelines specific to this population.</p></sec><sec id="jpr370100-sec-0040" sec-type="conclusions"><label>4</label><title>CONCLUSION</title><p>Considering these diagnostic challenges, our case highlights the need for revised pediatric IgG4‐RD criteria and multicenter studies to better define the disease in children, and provides direction for prognostic factors and disease severity scales in pediatric populations.</p></sec><sec id="jpr370100-sec-0060" sec-type="COI-statement"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare no conflicts of interest.</p></sec><sec id="jpr370100-sec-0070"><title>ETHICS STATEMENT</title><p>Written informed consent was obtained from the parents to share this case.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data" id="jpr370100-suppl-0001" orientation="portrait" position="float"><caption><p>Supporting information.</p></caption><media orientation="portrait" position="float" xlink:href="JPR3-7-142-s001.docx" xmlns:xlink="http://www.w3.org/1999/xlink"/></supplementary-material></sec></body><back><ack id="jpr370100-sec-0050"><title>ACKNOWLEDGMENTS</title><p>The authors thank Dr. Benjamin Cloyd and Dr. Ali Sanati‐Mehrizy for the care they provided for this patient and Dr. Lugen Chen for contributing liver and pancreas histology photomicrographs. The authors would also like to thank the patient and her parents for consenting to share this case. Racha Khalaf receives funding from the Cystic Fibrosis Foundation (005206Q123, 005583Q123).</p></ack><ref-list content-type="cited-references" id="jpr370100-bibl-0001"><title>REFERENCES</title><ref id="jpr370100-bib-0001"><label>1</label><mixed-citation id="jpr370100-cit-0001" publication-type="journal">
<string-name name-style="western">
<surname>Scheers</surname>
<given-names>I</given-names>
</string-name>, <string-name name-style="western">
<surname>Palermo</surname>
<given-names>JJ</given-names>
</string-name>, <string-name name-style="western">
<surname>Freedman</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Autoimmune pancreatitis in children: characteristic features, diagnosis, and management</article-title>. <source>Am J Gastroenterol</source>. <year>2017</year>;<volume>112</volume>:<fpage>1604</fpage>‐<lpage>1611</lpage>.<pub-id pub-id-type="pmid">28374818</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1038/ajg.2017.85</pub-id><pub-id pub-id-type="pmcid">PMC5908471</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0002"><label>2</label><mixed-citation id="jpr370100-cit-0002" publication-type="journal">
<string-name name-style="western">
<surname>Gallo</surname>
<given-names>C</given-names>
</string-name>, <string-name name-style="western">
<surname>Dispinzieri</surname>
<given-names>G</given-names>
</string-name>, <string-name name-style="western">
<surname>Zucchini</surname>
<given-names>N</given-names>
</string-name>, <string-name name-style="western">
<surname>Invernizzi</surname>
<given-names>P</given-names>
</string-name>, <string-name name-style="western">
<surname>Massironi</surname>
<given-names>S</given-names>
</string-name>. <article-title>Autoimmune pancreatitis: cornerstones and future perspectives</article-title>. <source>World J Gastroenterol</source>. <year>2024</year>;<volume>30</volume>:<fpage>817</fpage>‐<lpage>832</lpage>.<pub-id pub-id-type="pmid">38516247</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.3748/wjg.v30.i8.817</pub-id><pub-id pub-id-type="pmcid">PMC10950636</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0003"><label>3</label><mixed-citation id="jpr370100-cit-0003" publication-type="journal">
<string-name name-style="western">
<surname>Scheers</surname>
<given-names>I</given-names>
</string-name>, <string-name name-style="western">
<surname>Palermo</surname>
<given-names>JJ</given-names>
</string-name>, <string-name name-style="western">
<surname>Freedman</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Recommendations for diagnosis and management of autoimmune pancreatitis in childhood</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. <year>2018</year>;<volume>67</volume>:<fpage>232</fpage>‐<lpage>236</lpage>.<pub-id pub-id-type="pmid">29746340</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1097/MPG.0000000000002028</pub-id><pub-id pub-id-type="pmcid">PMC6059991</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0004"><label>4</label><mixed-citation id="jpr370100-cit-0004" publication-type="journal">
<string-name name-style="western">
<surname>Mack</surname>
<given-names>CL</given-names>
</string-name>, <string-name name-style="western">
<surname>Adams</surname>
<given-names>D</given-names>
</string-name>, <string-name name-style="western">
<surname>Assis</surname>
<given-names>DN</given-names>
</string-name>, et al. <article-title>Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases</article-title>. <source>Hepatology</source>. <year>2020</year>;<volume>72</volume>:<fpage>671</fpage>‐<lpage>722</lpage>.<pub-id pub-id-type="pmid">31863477</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/hep.31065</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0005"><label>5</label><mixed-citation id="jpr370100-cit-0005" publication-type="journal">
<string-name name-style="western">
<surname>Hennes</surname>
<given-names>EM</given-names>
</string-name>, <string-name name-style="western">
<surname>Zeniya</surname>
<given-names>M</given-names>
</string-name>, <string-name name-style="western">
<surname>Czaja</surname>
<given-names>AJ</given-names>
</string-name>, et al. <article-title>Simplified criteria for the diagnosis of autoimmune hepatitis</article-title>. <source>Hepatology</source>. <year>2008</year>;<volume>48</volume>:<fpage>169</fpage>‐<lpage>176</lpage>.<pub-id pub-id-type="pmid">18537184</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/hep.22322</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0006"><label>6</label><mixed-citation id="jpr370100-cit-0006" publication-type="journal">
<string-name name-style="western">
<surname>Umehara</surname>
<given-names>H</given-names>
</string-name>, <string-name name-style="western">
<surname>Okazaki</surname>
<given-names>K</given-names>
</string-name>, <string-name name-style="western">
<surname>Kawa</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4‐RD</article-title>. <source>Modern Rheumatol</source>. <year>2021</year>;<volume>31</volume>:<fpage>529</fpage>‐<lpage>533</lpage>.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1080/14397595.2020.1859710</pub-id><pub-id pub-id-type="pmid">33274670</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0007"><label>7</label><mixed-citation id="jpr370100-cit-0007" publication-type="journal">
<string-name name-style="western">
<surname>Tanaka</surname>
<given-names>A</given-names>
</string-name>, <string-name name-style="western">
<surname>Notohara</surname>
<given-names>K</given-names>
</string-name>. <article-title>Immunoglobulin G4 (IgG4)‐related autoimmune hepatitis and IgG4‐hepatopathy: a histopathological and clinical perspective</article-title>. <source>Hepatol Res</source>. <year>2021</year>;<volume>51</volume>:<fpage>850</fpage>‐<lpage>859</lpage>.<pub-id pub-id-type="pmid">34165225</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1111/hepr.13683</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0008"><label>8</label><mixed-citation id="jpr370100-cit-0008" publication-type="journal">
<string-name name-style="western">
<surname>Rizvi</surname>
<given-names>I</given-names>
</string-name>, <string-name name-style="western">
<surname>Solipuram</surname>
<given-names>D</given-names>
</string-name>, <string-name name-style="western">
<surname>Kaur</surname>
<given-names>N</given-names>
</string-name>, <string-name name-style="western">
<surname>Komel</surname>
<given-names>A</given-names>
</string-name>, <string-name name-style="western">
<surname>Batool</surname>
<given-names>S</given-names>
</string-name>, <string-name name-style="western">
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>. <article-title>The enigma of sickle cell hepatopathy: pathophysiology, clinical manifestations and therapy</article-title>. <source>Br J Haematol</source>. <year>2024</year>:<fpage>1</fpage>‐<lpage>16</lpage>.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1111/bjh.19620</pub-id><pub-id pub-id-type="pmid">38978231</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0009"><label>9</label><mixed-citation id="jpr370100-cit-0009" publication-type="journal">
<string-name name-style="western">
<surname>Lopinto</surname>
<given-names>J</given-names>
</string-name>, <string-name name-style="western">
<surname>Gendreau</surname>
<given-names>S</given-names>
</string-name>, <string-name name-style="western">
<surname>Berti</surname>
<given-names>E</given-names>
</string-name>, <string-name name-style="western">
<surname>Bartolucci</surname>
<given-names>P</given-names>
</string-name>, <string-name name-style="western">
<surname>Habibi</surname>
<given-names>A</given-names>
</string-name>, <string-name name-style="western">
<surname>Dessap</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta‐analysis</article-title>. <source>Haematologica</source>. <year>2022</year>;<volume>107</volume>:<fpage>1914</fpage>‐<lpage>1921</lpage>.<pub-id pub-id-type="pmid">35021607</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.3324/haematol.2021.280105</pub-id><pub-id pub-id-type="pmcid">PMC9335109</pub-id></mixed-citation></ref><ref id="jpr370100-bib-0010"><label>10</label><mixed-citation id="jpr370100-cit-0010" publication-type="journal">
<string-name name-style="western">
<surname>Leonard</surname>
<given-names>A</given-names>
</string-name>, <string-name name-style="western">
<surname>Godiwala</surname>
<given-names>N</given-names>
</string-name>, <string-name name-style="western">
<surname>Herrera</surname>
<given-names>N</given-names>
</string-name>, <string-name name-style="western">
<surname>McCarter</surname>
<given-names>R</given-names>
</string-name>, <string-name name-style="western">
<surname>Sharron</surname>
<given-names>M</given-names>
</string-name>, <string-name name-style="western">
<surname>Meier</surname>
<given-names>ER</given-names>
</string-name>. <article-title>Early initiation of inhaled corticosteroids does not decrease acute chest syndrome morbidity in pediatric patients with sickle cell disease</article-title>. <source>Blood Cells Mol Dis</source>. <year>2018</year>;<volume>71</volume>:<fpage>55</fpage>‐<lpage>62</lpage>.<pub-id pub-id-type="pmid">29550053</pub-id>
<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.bcmd.2018.03.001</pub-id></mixed-citation></ref></ref-list></back></article>